Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Selpercatinib for treating advanced solid tumours with RET gene fusion in people aged 12 years and older	Selpercatinib (LOXO-292; LY3527723)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Selumetinib for treating symptomatic, inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in adults	Selumetinib (AZD6244; ARRY-142886)	Plexiform neurofibromas	Neurological Cancer , Neurology	2023	View \| Download
Semaglutide for non-cirrhotic non-alcoholic steatohepatitis	Semaglutide (Ozempic)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2023	View \| Download
Semaglutide for treating overweight or obesity with cardiovascular disease	Semaglutide (Ozempic)	Cardiovascular disease (CVD) , Obesity	Cardiovascular System , Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Serplulimab with chemotherapy for treating previously untreated extensive stage small-cell lung cancer	Serplulimab (HLX10)	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2023	View \| Download
Sirolimus-eluting collagen implant for preventing vascular access failure in end stage renal disease patients undergoing haemodialysis	Sirolimus-eluting collagen implant	Renal disease	Cardiovascular System , Immunology	2023	View \| Download
Sparsentan for treating primary IgA nephropathy	Sparsentan (RE-021; PS433540)	IgA nephropathy	Immunology , Nephrology	2023	View \| Download
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed and/or refractory multiple myeloma	Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) , Subcutaneous isatuximab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2023	View \| Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma	Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi)	Follicular lymphoma , Marginal zone lymphoma (MZL)	Haematological Cancer and Lymphomas	2023	View \| Download
Tarlatamab for relapsed/refractory small-cell lung cancer	Tarlatamab	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2023	View \| Download